# Exponent Inc: Form 10-Q for the period ended Sep 30, 2022

- Company: [Exponent Inc](/companies/expo.md) (CIK 851520)
- Form: 10-Q
- Filed: 2022-11-04
- Accepted by EDGAR: Nov 4, 2022, 16:26 ET
- Period: 2022-09-30
- Accession: 0000950170-22-022200
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/851520/000095017022022200/expo-20220930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/851520/000095017022022200/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-07-02 to 2022-09-30 | $127.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2022-01-01 to 2022-09-30 | $385.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months, 2022-07-02 to 2022-09-30 | $36.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2022-01-01 to 2022-09-30 | $118.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2022-07-02 to 2022-09-30 | $9.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2022-01-01 to 2022-09-30 | $21.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-07-02 to 2022-09-30 | $24.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2022-01-01 to 2022-09-30 | $79.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-07-02 to 2022-09-30 | $0.47 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2022-01-01 to 2022-09-30 | $1.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-07-02 to 2022-09-30 | $0.47 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-01-01 to 2022-09-30 | $1.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-07-02 to 2022-09-30 | 52,008,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2022-01-01 to 2022-09-30 | 52,489,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2022-01-01 to 2022-09-30 | $53.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2022-01-01 to 2022-09-30 | $9.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2022-01-01 to 2022-09-30 | $37.1m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2022-01-01 to 2022-09-30 | $142.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-09-30 | $148.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-09-30 | $332.5m | us-gaap:AssetsCurrent |
| Total assets | at 2022-09-30 | $559.0m | us-gaap:Assets |
| Current liabilities | at 2022-09-30 | $137.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-09-30 | $239.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2022-09-30 | $319.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 40,024 characters.

The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included herein and with our audited consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021, which are contained in our fiscal 2021 Annual Report on Form 10-K, which was filed with the U.S. Securities and Exchange Commission on February 25, 2022 (our “2021 Annual Report”).

### Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of our management, as well as assumptions made by and information currently available to our management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to us or our management, identify such forward-looking statements. Such statements reflect the current views of us or our management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, our actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the global economic downturn, the COVID-19 pandemic (including factors relating to measures implemented by governmental authorities or by us to promote the safety of our employees, vendors and clients; other direct and indirect impacts on our business and the businesses of our clients, vendors and other partners; impacts which may, among other things, adversely affect our clients’ ability to utilize our services at the levels they have previously; disruptions of access to our facilities or those of our clients or third parties; and increased and potentially significant economic uncertainty and volatility, including credit and collectability risks and potential disruptions of capital and credit markets), the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in this Quarterly Report under the heading “Risk Factors” and elsewhere in this report. The inclusion of such forward-looking information should not be regarded as a representation by the us or any other person that the future events, plans, or expectations we contemplated will be achieved. Due to such uncertainties and risks, you are warned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. We do not intend to release publicly any updates or revisions to any such forward-looking statements.

### Business Overview

Exponent, Inc., is an engineering and scientific consulting firm that provides solutions to complex problems. Our multidisciplinary team of scientists, engineers and business consultants brings together more than 90 different technical disciplines to solve complicated issues facing industry and business today. Our services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property and impending litigation.

### CRITICAL ACCOUNTING ESTIMATES

There have been no significant changes in our critical accounting estimates during the nine months ended September 30, 2022, as compared to the critical accounting estimates disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our 2021 Annual Report.

- 20 -

### RESULTS OF CONSOLIDATED OPERATIONS

### Executive Summary

Revenues for the third quarter of 2022 increased 9% to $127,179,000 as compared to $116,405,000 during the same period last year. Revenues before reimbursements for the third quarter of 2022 increased 6% to $115,143,000 as compared to $108,467,000 during the same period last year.

During the third quarter of 2022, our proactive engagements within consumer products and transportation remained a key driver of our performance as demand for our work related to virtual reality, wearable technologies, and energy storage increased. At the same time, our reactive business continued to benefit from an increase in litigation activity and a diversified portfolio of product safety- and recall-related work, particularly in the life sciences space.

Net income decreased 1% to $24,442,000 during the third quarter of 2022 as compared to $24,574,000 during the same period last year. Diluted earnings per share increased to $0.47 per share as compared to $0.46 in the same period last year.

We remain focused on selectively adding top talent and developing the skills necessary to expand our market position and providing clients with in-depth scientific research and analysis to determine what happened and how to prevent failures or exposures in the future. We also remain focused on capitalizing on emerging growth areas, managing other operating expenses, generating cash from operations, maintaining a strong balance sheet and undertaking activities such as share repurchases and dividends to enhance shareholder value.

### Overview of the Three Months Ended September 30, 2022

During the third quarter of 2022, billable hours increased 5% to 365,000 as compared to 348,000 during the same period last year. Our utilization decreased to 73% during the third quarter of 2022 as compared to 76% during the same period last year. Technical full-time equivalent employees increased 8% to 958 during the third quarter of 2022 as compared to 883 during the same period last year. We continue to selectively hire key talent to expand our capabilities.

### Three Months Ended September 30, 2022 compared to Three Months Ended October 1, 2021

### Revenues

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Engineering and Other Scientific | $107,403 | $97,100 | 10.6% |
| Percentage of total revenues | 84.5% | 83.4% |  |
| Environmental and Health | 19,776 | 19,305 | 2.4% |
| Percentage of total revenues | 15.5% | 16.6% |  |
| Total revenues | $127,179 | $116,405 | 9.3% |

The increase in revenues for our Engineering and Other Scientific segment was due to an increase in billable hours and an increase in billing rates. During the third quarter of 2022, billable hours for this segment increased by 6% to 291,000 as compared to 275,000 during the same period last year. Utilization for this segment decreased to 76% during the third quarter of 2022 as compared to 78% during the same period last year. The increase in billable hours was driven by an increase in demand for our services across the consumer products, utilities, and automotive sectors. Utilization during the second quarter of 2021 was historically strong. Technical full-time equivalent employees in this segment increased 10% to 742 during the third quarter of 2022 as compared to 675 for the same period last year due to our recruiting and retention efforts.

The increase in revenues for our Environmental and Health segment was due to an increase in billable hours and an increase in billing rates. Excluding the impact of foreign exchange, revenues for this segment increased 7.3% during the third quarter of 2022. During the third quarter of 2022, billable hours for this segment increased by 1% to 74,000 as compared to 73,000 during the same period last year. Utilization in this segment decreased to 66% during

- 21 -

the third quarter of 2022 as compared to 68% during the same period last year. The increase in revenues was due to expansion of our health data science work. The decrease in utilization was due to investments in recruiting and marketing in our Health Practice. Technical full-time equivalent employees in this segment increased 4% to 216 during the third quarter of 2022 as compared to 208 during the same period last year due to our recruiting and retention efforts.

### Compensation and Related Expenses

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Compensation and related expenses | $62,779 | $64,138 | -2.1% |
| Percentage of total revenues | 49.4% | 55.1% |  |

The decrease in compensation and related expenses during the third quarter of 2022 was due to a change in the value of assets associated with our deferred compensation plan, partially offset by an increase in payroll expense and an increase in fringe benefits. During the third quarter of 2022, deferred compensation expense decreased by $4,667,000 with a corresponding decrease to other income, net, as compared to the same period last year, due to the change in value of assets associated with our deferred compensation plan. This decrease consisted of a decrease in the value of plan assets of $4,925,000 during the third quarter of 2022 as compared to a decrease in the value of plan assets of $258,000 during the same period last year. Payroll expense increased by $2,690,000 and fringe benefits increased by $307,000 during the third quarter of 2022 due to the impact of our annual salary adjustments and an increase in technical full-time equivalent employees. We expect our compensation expense, excluding the change in value of deferred compensation plan assets, to increase as we selectively add new talent and adjust compensation to market conditions.

### Other Operating Expenses

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Other operating expenses | $8,822 | $8,017 | 10.0% |
| Percentage of total revenues | 6.9% | 6.9% |  |

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. The increase in other operating expenses during the third quarter of 2022 was primarily due to an increase in occupancy expense of $400,000, an increase in information technology related expenses of $253,000, and an increase in office expenses of $132,000. The increases in occupancy expenses and office expenses were due to growth in technical full-time equivalent employees and the transition back to our offices from a fully remote work environment. The increases in information technology related expenses were due to continued investment in our corporate infrastructure. We expect other operating expenses to grow as we selectively add new talent, make investments in our corporate infrastructure, and transition our workforce back to our offices as COVID-19 pandemic related business restrictions are lifted.

### Reimbursable Expenses

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Reimbursable expenses | $12,036 | $7,938 | 51.6% |
| Percentage of total revenues | 9.5% | 6.8% |  |

- 22 -

The amount of reimbursable expenses will vary from quarter to quarter depending on the nature of our projects. The increase in reimbursable expenses during the third quarter of 2022 was primarily due to an increase in project-related travel and other project-related expenses as COVID-19 pandemic-related business and travel restrictions eased.

### General and Administrative Expenses

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| General and administrative expenses | $6,729 | $4,193 | 60.5% |
| Percentage of total revenues | 5.3% | 3.6% |  |

The increase in general and administrative expenses was primarily due to an increase in travel and meals of $1,710,000, an increase in outside consulting expense of $485,000, an increase in recruiting expenses of 167,000, and several other individually insignificant increases. The increase in travel and meals was due to a firm-wide managers' meeting held during the third quarter of 2022 and the continued easing of COVID-19 pandemic-related business and travel restrictions. The increase in outside consulting expense was due to several ongoing projects associated with investments in our corporate infrastructure. The increases in recruiting expenses was due to the increase in technical full-time equivalent employees. We expect general and administrative expenses to increase as we selectively add new talent, expand our business development and staff development initiatives, and increase travel and meal expenses as COVID-19 pandemic related business restrictions phase out.

### Operating Income

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Engineering and Other Scientific | $39,385 | $36,676 | 7.4% |
| Environmental and Health | 6,378 | 5,851 | 9.0% |
| Total segment operating income | 45,763 | 42,527 | 7.6% |
| Corporate operating expense | (8,950) | (10,408) | -14.0% |
| Total operating income | $36,813 | $32,119 | 14.6% |

The increase in operating income for our Engineering and Other Scientific segment during the third quarter of 2022 as compared to the same period last year was due to an increase in revenues partially offset by an increase in expenses. The increase in revenues was driven by demand for our services across the consumer products, utilities, and automotive sectors. The increase in operating income for our Environmental and Health segment was due to an increase in revenues. The increase in revenues was driven by expansion of our health data science work.

- 23 -

Certain operating expenses are excluded from the Company’s measure of segment operating income. These expenses include the costs associated with our human resources, finance, information technology, and business development groups; the deferred compensation expense/benefit due to the change in value of assets associated with our deferred compensation plan; stock-based compensation associated with restricted stock unit and stock option awards; and the change in our allowance for contract losses and doubtful accounts.

The decrease in corporate operating expenses during the third quarter of 2022 as compared to the same period last year was primarily due to a decrease in deferred compensation expense partially offset by an increase in the costs associated with our human resources, finance, information technology and business development groups. During the third quarter of 2022, deferred compensation expense decreased $4,667,000, with a corresponding decrease to other income, net, as compared to the same period last year, due to the change in value of assets associated with our deferred compensation plan. This decrease consisted of a decrease in the value of plan assets of $4,925,000 during the third quarter of 2022 as compared to a decrease in the value of plan assets of $258,000 during the same period last year.

### Other Income, Net

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Other income, net | $(3,337) | $270 | -1335.9% |
| Percentage of total revenues | -2.6% | 0.2% |  |

Other income, net, consists primarily of changes in the value of assets associated with our deferred compensation plan, interest income earned on available cash, cash equivalents and short-term investments, and rental income from leasing space in our Silicon Valley and Natick facilities. The decrease in other income, net, was primarily due to a change in the value of assets associated with our deferred compensation plan partially offset by an increase in the gain on foreign exchange, and an increase in interest income. During the third quarter of 2022, other income, net, decreased by $4,667,000 with a corresponding decrease to deferred compensation expense, as compared to the same period last year, due to a change in the value of assets associated with our deferred compensation plan. This decrease consisted of a decrease in the value of the plan assets of $4,925,000 during the third quarter of 2022 as compared to a decrease in the value of the plan assets of $258,000 during the same period last year. The increase in the gain on foreign exchange of $325,000 was due to an increase in the value of assets denominated in currencies that are not our functional currency. The increase in interest income of $625,000 was due to an increase in interest rates.

### Income Taxes

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Income taxes | $9,034 | $7,815 | 15.6% |
| Percentage of total revenues | 7.1% | 6.7% |  |
| Effective tax rate | 27.0% | 24.1% |  |

The increase in income tax expense was due to a decrease in the excess tax benefit associated with stock-based awards. There was no excess tax benefit associated with stock-based awards during the third quarter of 2022. The excess tax benefit associated with stock-based awards was $1,066,000 during the third quarter of 2021. Excluding the impact of the excess tax benefit, the effective tax rate would have been 27.4% during the third quarter of 2021.

### Nine Months Ended September 30, 2022 compared to Nine Months Ended October 1, 2021

### Revenues

- 24 -

*(in thousands, except percentages)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Engineering and Other Scientific | $321,168 | $288,848 | 11.2% |
| Percentage of total revenues | 83.2% | 81.9% |  |
| Environmental and Health | 64,770 | 63,915 | 1.3% |
| Percentage of total revenues | 16.8% | 18.1% |  |
| Total revenues | $385,938 | $352,763 | 9.4% |

The increase in revenues for our Engineering and Other Scientific segment was due to an increase in billable hours and an increase in billing rates. During the first nine months of 2022, billable hours for this segment increased by 4% to 874,000 as compared to 838,000 during the same period last year. Utilization for this segment decreased to 77% during the first nine months of 2022 as compared to 79% during the same period last year. Growth was driven by demand for Exponent’s services across a broad range of industries and use cases. In addition to the steady increase in litigation support and human participant studies, our multidisciplinary battery team continued to see demand for its solutions in electric vehicles and energy storage. Our work in international arbitrations and integrity management advisory services continued at strong levels. Technical full-time equivalent employees in this segment increased 6% to 725 during the first nine months of 2022 as compared to 682 for the same period last year due to our recruiting and retention efforts.

The increase in revenues for our Environmental and Health segment was due to an increase in billable hours and an increase in our realized billing rate. Excluding the impact of foreign exchange, revenues for this segment increased 4.3% during the first nine months of 2022. During the first nine months of 2022, billable hours for this segment increased by 2% to 236,000 as compared to 232,000 during the same period last year. Utilization in this segment decreased to 69% during the first nine months of 2022 as compared to 70% during the same period last year. This segment benefited from increased activity in litigation-related projects and support of human participant studies. Technical full-time equivalent employees in this segment increased by 4% to 219 during the first nine months of 2022 as compared to 211 during the same period last year due to our recruiting and retention efforts.

### Compensation and Related Expenses

*(in thousands, except percentages)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Compensation and related expenses | $189,982 | $210,491 | -9.7% |
| Percentage of total revenues | 49.2% | 59.7% |  |

The decrease in compensation and related expenses during the first nine months of 2022 was due to a change in the value of assets associated with our deferred compensation plan partially offset by an increase in payroll expense, an increase in fringe benefits, and an increase in bonus expense. During the first nine months of 2022, deferred compensation expense decreased $30,881,000 with a corresponding decrease to other income, net, as compared to the same period last year, due to the change in value of assets associated with our deferred compensation plan. This decrease consisted of a decrease in the value of plan assets of $20,884,000 during the first nine months of 2022 as compared to an increase in the value of plan assets of $9,997,000 during the same period last year. Payroll expense increased $7,157,000 during the first nine months of 2022 due to the increase in technical full-time equivalent employees and the impact of our annual salary adjustments. Fringe benefits increased by $1,366,000 during the first nine months of 2022 due to the increase in technical full-time equivalent employees and the impact of our annual salary adjustments. Bonus expense increased by $1,210,000 during the first nine months of 2022 due to a corresponding increase to our bonus pool which is equal to 33% of income before income taxes, interest income, bonus expense, and stock-based compensation. We expect our compensation expense, excluding the change in value of deferred compensation plan assets, to increase as we selectively add new talent and adjust compensation to market conditions.

### Other Operating Expenses

- 25 -

*(in thousands, except percentages)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Other operating expenses | $25,742 | $23,848 | 7.9% |
| Percentage of total revenues | 6.7% | 6.8% |  |

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. The increase in other operating expenses during the first nine months of 2022 was primarily due to an increase in occupancy expense of $763,000, an increase in information technology related expenses of $578,000 and an increase in depreciation expense of $281,000. The increase in occupancy expenses was due to growth in technical full-time equivalent employees and the transition back to our offices from a fully remote work environment. The increases in information technology related expenses and depreciation expense were due to continued investment in our corporate infrastructure. We expect other operating expenses to grow as we selectively add new talent, make investments in our corporate infrastructure, and transition our workforce back to our offices as COVID-19 pandemic-related business restrictions are lifted.

### Reimbursable Expenses

*(in thousands, except percentages)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Reimbursable expenses | $34,707 | $22,249 | 56.0% |
| Percentage of total revenues | 9.0% | 6.3% |  |

The amount of reimbursable expenses will vary from quarter to quarter depending on the nature of our projects. The increase in reimbursable expenses during the first nine months of 2022 was primarily due to an increase in project-related travel and other project-related expenses as COVID-19 business and travel restrictions eased.

### General and Administrative Expenses

*(in thousands, except percentages)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| General and administrative expenses | $16,700 | $10,626 | 57.2% |
| Percentage of total revenues | 4.3% | 3.0% |  |

The increase in general and administrative expenses was primarily due to an increase in travel and meals of $3,303,000, an increase in outside consulting expense of $1,050,000, an increase in recruiting expenses of $562,000, an increase in marketing and business development expenses of $268,000 and several other individually insignificant increases. The increase in travel and meals was due to a firm-wide managers' meeting held during the third quarter of 2022 and the continued easing of COVID-19 pandemic-related business and travel restrictions. The increase in outside consulting expense was due to several ongoing projects associated with investments in our corporate infrastructure. The increase in recruiting expense was due to the increase in technical full-time equivalent employees. The increase in marketing and business development expenses was due to an increase in our business development activities. We expect general and administrative expenses to increase as we selectively add new talent, expand our business development and staff development initiatives, and increase travel and meal expenses as COVID-19 pandemic related business restrictions phase out.

### Operating Income

- 26 -

*(in thousands, except percentages)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Engineering and Other Scientific | $117,907 | $108,646 | 8.5% |
| Environmental and Health | 21,059 | 21,265 | -1.0% |
| Total segment operating income | 138,966 | 129,911 | 7.0% |
| Corporate operating expense | (20,159) | (44,362) | -54.6% |
| Total operating income | $118,807 | $85,549 | 38.9% |

The increase in operating income for our Engineering and Other Scientific segment during the first nine months of 2022 as compared to the same period last year was due to an increase in revenues partially offset by an increase in expenses. The increase in revenues was due to an increase in billable hours and an increase in billing rates. Growth was driven by strong demand for Exponent’s services across a broad range of industries and use cases. In addition to the steady increase in litigation support and human participant studies, our multidisciplinary battery team continued to see demand for its solutions in electric vehicles and energy storage. Our work in international arbitrations and integrity management advisory services continued at strong levels. The decrease in operating income for our Environmental and Health segment was due to investments in recruiting and marketing in our Health Practice.

Certain operating expenses are excluded from our measure of segment operating income. These expenses include the costs associated with our human resources, finance, information technology, and business development groups; the deferred compensation expense/benefit due to the change in value of assets associated with our deferred compensation plan; stock-based compensation associated with restricted stock unit and stock option awards; and the change in our allowance for contract losses and doubtful accounts.

The decrease in corporate operating expenses during the first nine months of 2022 as compared to the same period last year was primarily due to a decrease in deferred compensation expense partially offset by an increase in the costs associated with our human resources, finance, information technology and business development groups. During the first nine months of 2022, deferred compensation expense decreased $30,881,000, with a corresponding decrease to other income, net, as compared to the same period last year, due to the change in value of assets associated with our deferred compensation plan. This decrease consisted of a decrease in the value of plan assets of $20,884,000 during the first nine months of 2022 as compared to an increase in the value of plan assets of $9,997,000 during the same period last year.

### Other Income, Net

*(in thousands, except percentages)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Other income, net | $(17,092) | $11,633 | -246.9% |
| Percentage of total revenues | -4.4% | 3.3% |  |

Other income, net, consists primarily of changes in the value of assets associated with our deferred compensation plan, interest income earned on available cash, cash equivalents and short-term investments, and rental income from leasing space in our Silicon Valley and Natick facilities. The decrease in other income, net, was primarily due to a change in the value of assets associated with our deferred compensation plan partially offset by an increase in the realized gain on foreign exchange and an increase in interest income. During the first nine months of 2022, other income, net, decreased $30,881,000 with a corresponding decrease to deferred compensation expense, as compared to the same period last year, due to a change in the value of assets associated with our deferred compensation plan. This decrease consisted of a decrease in the value of the plan assets of $20,884,000 during the first nine months of 2022 as compared to an increase in the value of the plan assets of $9,997,000 during the same period last year. During the first nine months of 2022, other income, net, increased by $1,218,000 as compared to the same period last year due to a change in the realized gain/loss on foreign exchange. This increase consisted of a realized gain on foreign exchange of $776,000 during the first nine months of 2022 as compared to a realized loss on foreign exchange of $442,000 during the same period last year. During the first nine months of 2022, interest income increased by $780,000 as compared to the same period last year due to an increase in interest rates.

### Income Taxes

- 27 -

*(in thousands, except percentages)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 | Percent Change |
| --- | ---: | ---: | ---: |
| Income taxes | $21,909 | $16,360 | 33.9% |
| Percentage of total revenues | 5.7% | 4.6% |  |
| Effective tax rate | 21.5% | 16.8% |  |

The excess tax benefit associated with stock-based awards was $6,040,000 during the first nine months of 2022 as compared to $9,889,000 during the same period last year. Excluding the impact of the excess tax benefit, the effective tax rate would have been 27.5% during the first nine months of 2022 as compared to 27.0% during the same period last year. The increase in our effective tax rate, excluding the impact of the excess tax benefit, was due primarily to an increase in non-deductible officer compensation.

- 28 -

### LIQUIDITY AND CAPITAL RESOURCES

We believe our existing balances of cash, cash equivalents, and cash generated from operations will be sufficient to satisfy our working capital needs, capital expenditures, outstanding commitments, stock repurchases, dividends and other liquidity requirements over at least the next twelve months.

*(in thousands)*

|  | Nine Months Ended September 30, 2022 | October 1, 2021 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $53,237 | $70,378 |
| Net cash (used in) / provided by investing activities | (9,108) | 14,569 |
| Net cash used in financing activities | (190,556) | (52,766) |

We financed our business during the first nine months of 2022 through available cash. As of September 30, 2022, our cash and cash equivalents were $148,443,000 as compared to $297,687,000 at December 31, 2021.

Generally, our net cash provided by operating activities is used to fund our day to day operating activities. First quarter operating cash requirements are generally higher due to payment in the first quarter of our annual bonuses accrued during the prior year. Our largest source of operating cash flows is collections from our clients. Our primary uses of cash from operating activities are for employee related expenditures, leased facilities, taxes, and general operating expenses including marketing and travel.

The increase in net cash used in investing activities during the first nine months of 2022, as compared to the net cash provided by investing activities during the same period last year, was due to a decrease in the maturity of short-term investments partially offset by a decrease in the purchase of short-term investments and an increase in capital expenditures due to an increase in investment in our corporate infrastructure.

The increase in net cash used in financing activities during the first nine months of 2022, as compared to the same period last year, was due to an increase in repurchases of our common stock and an increase in dividends partially offset by a reduction in payroll taxes for restricted stock units.

We expect to continue our investing activities, including capital expenditures. Furthermore, cash reserves may be used to repurchase shares of common stock under our stock repurchase programs, pay dividends, or strategically acquire professional service firms that are complementary to our business.

We maintain a nonqualified deferred compensation plan for the benefit of a select group of highly compensated employees. Vested amounts due under the plan of $85,453,000 were recorded as a long-term liability on our unaudited condensed consolidated balance sheet at September 30, 2022. Vested amounts due under the plan of $9,049,000 were recorded as a current liability on our unaudited condensed consolidated balance sheet at September 30, 2022. Our assets that are earmarked to pay benefits under the plan are held in a rabbi trust and are subject to the claims of our creditors. As of September 30, 2022, invested amounts under the plan of $83,722,000 were recorded as a long-term asset on our unaudited condensed consolidated balance sheet. As of September 30, 2022, invested amounts under the plan of $10,857,000 were recorded as a current asset on our unaudited condensed consolidated balance sheet.

As permitted under Delaware law, we have agreements whereby we indemnify our officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity. The indemnification period covers all pertinent events and occurrences during the officer’s or director’s lifetime. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited; however, we have director and officer insurance coverage that reduces our exposure and enables us to recover a portion of any future amounts paid.

- 29 -

### Non-GAAP Financial Measures

Regulation G, Conditions for Use of Non-Generally Accepted Accounting Principles ("Non-GAAP") Financial Measures, and other U.S. Securities and Exchange Commission (“SEC”) rules and regulations define and prescribe the conditions for use of Non-GAAP financial information. Generally, a Non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. We closely monitor two financial measures, EBITDA and EBITDAS, which meet the definition of Non-GAAP financial measures. We define EBITDA as net income before income taxes, net interest income, depreciation and amortization. We define EBITDAS as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. These measures are used to evaluate our financial results, develop budgets and determine employee compensation. These measures, however, should be considered in addition to, and not as a substitute for or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the Non-GAAP measures to the nearest comparable GAAP measure is set forth below.

The following table shows EBITDA (determined as shown in the reconciliation table below) as a percentage of revenues before reimbursements for the three months ended September 30, 2022 and October 1, 2021:

*(in thousands, except percentages)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Nine Months Ended September 30, 2022 | October 1, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Revenues before reimbursements | $115,143 | $108,467 | $351,231 | $330,514 |
| EBITDA | $34,561 | $34,021 | $106,105 | $102,071 |
| EBITDA as a % of revenues before reimbursements | 30.0% | 31.4% | 30.2% | 30.9% |

- 30 -

The decrease in EBITDA as a percentage of revenues before reimbursements during the third quarter of 2022 as compared to the same period last year was primarily due to the decrease in utilization and an increase in other operating and general and administrative expenses. Our utilization decreased to 73% during the third quarter of 2022 as compared to 76% during the same period last year. Utilization during the third quarter of 2021 was historically strong. Other operating and general and administrative expenses increased during the third quarter of 2022 due to an increase in travel and meals associated with a firm-wide managers' meeting held during the third quarter of 2022 and the continued easing of COVID-19 pandemic-related business and travel restrictions, an increase in technical full-time equivalent employees, investments in our corporate infrastructure, and an increase in marketing and business development activities.

The decrease in EBITDA as a percentage of revenues before reimbursements during the first nine months of 2022 as compared to the same period last year was primarily due to a decrease in utilization and an increase in other operating and general and administrative expenses. Other operating and general and administrative expenses increased during the first nine months of 2022 due to an increase in travel and meals associated with a firm-wide managers' meeting held during the third quarter of 2022 and the continued easing of COVID-19 pandemic-related business and travel restrictions, an increase in technical full-time equivalent employees, investments in our corporate infrastructure, and an increase in marketing and business development activities.

The following table is a reconciliation of EBITDA and EBITDAS to the most comparable GAAP measure, net income, for the three and nine months ended September 30, 2022 and October 1, 2021:

*(in thousands)*

|  | Three Months Ended September 30, 2022 | October 1, 2021 | Nine Months Ended September 30, 2022 | October 1, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Net income | $24,442 | $24,574 | $79,806 | $80,822 |
| Add back (subtract): |  |  |  |  |
| Income taxes | 9,034 | 7,815 | 21,909 | 16,360 |
| Interest income, net | (638) | (13) | (834) | (54) |
| Depreciation and amortization | 1,723 | 1,645 | 5,224 | 4,943 |
| EBITDA | 34,561 | 34,021 | 106,105 | 102,071 |
| Stock-based compensation | 4,605 | 4,365 | 16,072 | 15,239 |
| EBITDAS | $39,166 | $38,386 | $122,177 | $117,310 |

- 31 -

## Market risk

As filed, 2,809 characters.

We are exposed to interest rate risk associated with our balances of cash and cash equivalents. We manage our interest rate risk by maintaining an investment portfolio primarily consisting of debt instruments with high credit quality and relatively short average effective maturities in accordance with our investment policy. The maximum effective maturity of any issue in our portfolio is 3 years and the maximum average effective maturity of the portfolio cannot exceed 12 months. If interest rates were to instantaneously increase or decrease by 100 basis points, the change in the fair market value of our portfolio of cash equivalents would not have a material impact on our financial statements. We do not use derivative financial instruments in our portfolio. There have not been any material changes during the period covered by this Quarterly Report on Form 10-Q to our interest rate risk exposures, or how these exposures are managed. Notwithstanding our efforts to manage interest rate risk, there can be no assurances that we will be adequately protected against the risks associated with interest rate fluctuations.

We have foreign currency risk related to our revenues and expenses denominated in currencies other than the U.S. dollar, primarily the British Pound, the Euro, the Chinese Yuan, and the Hong Kong Dollar. Accordingly, changes in exchange rates may negatively affect the revenues and net income of our foreign subsidiaries as expressed in U.S. dollars.

At September 30, 2022, we had net assets of approximately $14.4 million with a functional currency of the British Pound, net assets of approximately $3.4 million with a functional currency of the Chinese Yuan, and net assets of approximately $5.5 million with a functional currency of the Hong Kong Dollar associated with our operations in the United Kingdom, China, and Hong Kong, respectively.

We also have foreign currency risk related to foreign currency transactions and monetary assets and liabilities denominated in currencies that are not the functional currency. We have experienced and will continue to experience fluctuations in our net income as a result of gains (losses) on these foreign currency transactions and the remeasurement of monetary assets and liabilities. At September 30, 2022, we had net assets denominated in the non-functional currency of approximately $8.3 million.

We do not use foreign exchange contracts to hedge any foreign currency exposures. To date, the impacts of foreign currency exchange rate changes on our consolidated revenues and consolidated net income have not been significant. However, our continued international growth increases our exposure to exchange rate fluctuations and as a result such fluctuations could have a significant impact on our future results of operations.

## Controls and procedures

As filed, 1,726 characters.

(a) Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this quarterly report. Based on that evaluation, the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, concluded that, as of September 30, 2022, the Company’s disclosure controls and procedures were effective.

We review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis, to improve our controls and procedures over time and to correct any deficiencies that we may discover in the future. Our goal is to ensure that our senior management has timely access to all material financial and non-financial information concerning our business. While we believe the present design of our disclosure controls and procedures is effective to achieve our goal, future events affecting our business may cause us to significantly modify our disclosure controls and procedures.

(b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the three-month period ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

- 32 -

## Risk factors

As filed, 147 characters.

There have been no material changes from risk factors as previously discussed under the heading “Risk Factors” in the Company’s 2021 Annual Report.

Filed Nov 4, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-022200. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.